Table 1 patients’ characteristics and drug regimen
Patients (disease) | BMI, kg/m2 | Disease duration, months | Current use of immunosuppressant drugs |
|---|---|---|---|
I (DM) | 30.5 | 61 | AZA |
II (DM) | 38.6 | 60 | CQ; MTX; CP |
III (DM) | 38.2 | 151 | None |
IV (PM) | 27.9 | 23 | AZA |
V (DM) | 21.4 | 75 | CQ; CP |
VI (DM) | 26.5 | 52 | AZA; MTX; Prednisone |
VII (PM) | 31.4 | 99 | MTX 15 |
VIII (PM) | 32.4 | 26 | AZA; MTX |
IX (DM) | 23.5 | 82 | MTX |
X (DM) | 27.4 | 37 | HCQ; AZA |
XI (PM) | 25.2 | 38 | MMF |
XII (DM) | 43.0 | 93 | AZA |
XIII (DM) | 37.7 | 48 | AZA |
All patients, mean (SD) | 31 (6.6) | 65 (35) | Not applicable |